Samuel Peter Heilbroner (Samuel P Heilbroner)

Years Active: 2019-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Samuel Peter Heilbroner, Reed Few, Judith Mueller, Jitesh Chalwa, Francois Charest, Somasekhar Suryadevara, Christine Kratt, Andres Gomez-Caminero, Brian Dreyfus, Tomas G Neilan
Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach. Journal for immunotherapy of cancer 9 (10) (2022)
Samuel Peter Heilbroner, Eric P Xanthopoulos, Donna Buono, Daniel Carrier, Ben Y Durkee, Michael Corradetti, Tony J C Wang, Alfred I Neugut, Dawn L Hershman, Simon K Cheng
Efficacy and cost of high-frequency IGRT in elderly stage III non-small-cell lung cancer patients. PloS one 16 (5) (2021)
Kunal R Chaudhary, Sherry X Yan, Samuel Peter Heilbroner, Joshua R Sonett, Mark B Stoopler, Catherine Shu, Balazs Halmos, Tony J C Wang, Tom K Hei, Simon K Cheng
Effects of β-Adrenergic Antagonists on Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer. Journal of clinical medicine 8 (5) (2019)

Samuel Peter Heilbroner.css-eqlu8i{font-size:small;padding-left:4px;} (Samuel P Heilbroner)